FI962985A0 - Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi - Google Patents
Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksiInfo
- Publication number
- FI962985A0 FI962985A0 FI962985A FI962985A FI962985A0 FI 962985 A0 FI962985 A0 FI 962985A0 FI 962985 A FI962985 A FI 962985A FI 962985 A FI962985 A FI 962985A FI 962985 A0 FI962985 A0 FI 962985A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- preparation
- dosage form
- active ingredients
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4402379 | 1994-01-27 | ||
| DE4402379A DE4402379C2 (de) | 1994-01-27 | 1994-01-27 | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
| EP9404082 | 1994-12-08 | ||
| PCT/EP1994/004082 WO1995020394A1 (de) | 1994-01-27 | 1994-12-08 | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI962985A FI962985A (fi) | 1996-07-26 |
| FI962985A0 true FI962985A0 (fi) | 1996-07-26 |
| FI116880B FI116880B (fi) | 2006-03-31 |
Family
ID=6508812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962985A FI116880B (fi) | 1994-01-27 | 1996-07-26 | Menetelmä oraalisen lääkemuodon valmistamiseksi, jossa on kantaja happamalle vaikuttavalle aineelle |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5858344A (fi) |
| EP (1) | EP0741574B1 (fi) |
| JP (1) | JP3701971B2 (fi) |
| KR (1) | KR100439311B1 (fi) |
| AT (1) | ATE218371T1 (fi) |
| AU (1) | AU697353B2 (fi) |
| CA (1) | CA2182417C (fi) |
| CZ (1) | CZ291006B6 (fi) |
| DE (2) | DE4402379C2 (fi) |
| DK (1) | DK0741574T3 (fi) |
| ES (1) | ES2177622T3 (fi) |
| FI (1) | FI116880B (fi) |
| HU (1) | HU223317B1 (fi) |
| IL (1) | IL112435A (fi) |
| MY (1) | MY113340A (fi) |
| NO (1) | NO963143L (fi) |
| NZ (1) | NZ277777A (fi) |
| PL (1) | PL315619A1 (fi) |
| PT (1) | PT741574E (fi) |
| SK (1) | SK97296A3 (fi) |
| WO (1) | WO1995020394A1 (fi) |
| ZA (1) | ZA95638B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403367B1 (en) * | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
| DE19615820A1 (de) * | 1996-04-06 | 1997-10-09 | Holger Specht | Zahnpflegemittel und Verfahren zu seiner Herstellung |
| US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
| CA2938564C (en) | 2006-11-07 | 2017-04-11 | The Procter & Gamble Company | Fiber containing compositions and methods of making and using same |
| US7767248B2 (en) * | 2007-02-02 | 2010-08-03 | Overly Iii Harry J | Soft chew confectionary with high fiber and sugar content and method for making same |
| WO2022259848A1 (ja) | 2021-06-07 | 2022-12-15 | 国立大学法人筑波大学 | 高分子化バルプロ酸及びその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191762A (en) * | 1978-10-19 | 1982-09-14 | Merck & Co Inc | Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
| DE3366838D1 (en) * | 1982-03-01 | 1986-11-20 | Efamol Ltd | Pharmaceutical composition |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| EP0409432A3 (en) * | 1989-07-20 | 1991-12-11 | Warner-Lambert Company | Confectionery delivery system |
| CA2040865C (en) * | 1990-05-15 | 2002-07-23 | James L. Bergey | Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
-
1994
- 1994-01-27 DE DE4402379A patent/DE4402379C2/de not_active Expired - Fee Related
- 1994-12-08 DE DE59410133T patent/DE59410133D1/de not_active Expired - Lifetime
- 1994-12-08 HU HU9602041A patent/HU223317B1/hu not_active IP Right Cessation
- 1994-12-08 CA CA002182417A patent/CA2182417C/en not_active Expired - Fee Related
- 1994-12-08 US US08/693,101 patent/US5858344A/en not_active Expired - Lifetime
- 1994-12-08 CZ CZ19962213A patent/CZ291006B6/cs not_active IP Right Cessation
- 1994-12-08 WO PCT/EP1994/004082 patent/WO1995020394A1/de active IP Right Grant
- 1994-12-08 AT AT95904434T patent/ATE218371T1/de active
- 1994-12-08 KR KR1019960704025A patent/KR100439311B1/ko not_active IP Right Cessation
- 1994-12-08 PT PT95904434T patent/PT741574E/pt unknown
- 1994-12-08 ES ES95904434T patent/ES2177622T3/es not_active Expired - Lifetime
- 1994-12-08 EP EP95904434A patent/EP0741574B1/de not_active Expired - Lifetime
- 1994-12-08 JP JP51984995A patent/JP3701971B2/ja not_active Expired - Fee Related
- 1994-12-08 AU AU13127/95A patent/AU697353B2/en not_active Ceased
- 1994-12-08 DK DK95904434T patent/DK0741574T3/da active
- 1994-12-08 SK SK972-96A patent/SK97296A3/sk unknown
- 1994-12-08 NZ NZ277777A patent/NZ277777A/en not_active IP Right Cessation
- 1994-12-08 PL PL94315619A patent/PL315619A1/xx unknown
-
1995
- 1995-01-24 IL IL11243595A patent/IL112435A/en not_active IP Right Cessation
- 1995-01-26 ZA ZA95638A patent/ZA95638B/xx unknown
- 1995-01-26 MY MYPI95000183A patent/MY113340A/en unknown
-
1996
- 1996-07-26 NO NO963143A patent/NO963143L/no unknown
- 1996-07-26 FI FI962985A patent/FI116880B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE4402379A1 (de) | 1995-08-03 |
| JP3701971B2 (ja) | 2005-10-05 |
| AU1312795A (en) | 1995-08-15 |
| DE59410133D1 (de) | 2002-07-11 |
| FI962985A (fi) | 1996-07-26 |
| CA2182417A1 (en) | 1995-08-03 |
| HU9602041D0 (en) | 1996-09-30 |
| HU223317B1 (hu) | 2004-05-28 |
| PT741574E (pt) | 2002-11-29 |
| DK0741574T3 (da) | 2002-09-23 |
| CZ291006B6 (cs) | 2002-11-13 |
| ZA95638B (en) | 1995-10-25 |
| PL315619A1 (en) | 1996-11-25 |
| CZ221396A3 (en) | 1997-01-15 |
| IL112435A (en) | 1999-01-26 |
| WO1995020394A1 (de) | 1995-08-03 |
| AU697353B2 (en) | 1998-10-01 |
| KR970700505A (ko) | 1997-02-12 |
| JPH09511488A (ja) | 1997-11-18 |
| ATE218371T1 (de) | 2002-06-15 |
| EP0741574A1 (de) | 1996-11-13 |
| IL112435A0 (en) | 1995-03-30 |
| NZ277777A (en) | 1997-01-29 |
| US5858344A (en) | 1999-01-12 |
| DE4402379C2 (de) | 1997-09-25 |
| ES2177622T3 (es) | 2002-12-16 |
| MY113340A (en) | 2002-01-31 |
| FI116880B (fi) | 2006-03-31 |
| NO963143D0 (no) | 1996-07-26 |
| SK97296A3 (en) | 1997-04-09 |
| KR100439311B1 (ko) | 2005-08-17 |
| CA2182417C (en) | 2007-04-17 |
| NO963143L (no) | 1996-09-24 |
| HUT74434A (en) | 1996-12-30 |
| EP0741574B1 (de) | 2002-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
| EE04002B1 (et) | Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati | |
| BG103552A (en) | Therapeutical forms | |
| MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
| BR9510168A (pt) | Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição | |
| BR9607926A (pt) | Composição farmacêutica para o tratamento de hiperfosfatemia uso de carbonato de lantânio processo para a preparação de carbonato de lantânio e carbonato de lantânio | |
| ATE109000T1 (de) | System zur freisetzung von medikamenten und dessen herstellungsmethode. | |
| AU7534087A (en) | Sustained release pharmaceutical compositions in oral dosage form | |
| NZ501950A (en) | Medicinal compositions for application to mucosa | |
| DE69519685T2 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| BR0015256A (pt) | Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano | |
| TR199701294T1 (xx) | Amoksisilin ve klavulanik asitten olu�an terkip. | |
| BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
| HK1038179A1 (en) | New oral formulation for 5-ht4 agonists or antagonists | |
| IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
| NO174032C (no) | Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel | |
| ATE290858T1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
| FI962985A0 (fi) | Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi | |
| BR9913718A (pt) | Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico | |
| EP0230264A3 (en) | Pharmaceutical composition for nasal application, process for its preparation and its use | |
| UA40636C2 (uk) | Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату | |
| DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
| PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
| FR2803521B1 (fr) | Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose | |
| UA29179A (uk) | Спосіб профілактики карієсу зубів |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 116880 Country of ref document: FI |
|
| MM | Patent lapsed |